We observe that SNP-wise effects in genes in the well-known COVID-19 peak locus on chromosome 3 appear to be coherent with those from being prescribed M05B medication, with Bonferroni significance for the chemokine receptor genes CCR1, CCR3 and the gene LZTFL1 in the region chr3p21 (we Bonferroni corrected for number of genes and drug classes tested). This evidence concerns the gene CCR1 and COVID-19.